retatrutide and menstrual cycle Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Delivers Significant Hemoglobin A1C

doi: 10.1016/j.tem.2019.05.008 190 KieczykowskaMKocotJPadziorMMusikI

It plays a key role in detoxification and skin health

Conclusiones - La prevalencia de la ERC es elevada en la DM2 y la ERD y se asocia con un mayor riesgo cardiovascular, de mortalidad y de progresin a ERC terminal, lo que requiere un tratamiento precoz e intensivo para minimizar estas complicaciones

A large observational study involving approximately 460,000 adults prescribed GLP-1 therapies found that nearly 1 in 5 patients developed at least 1 nutrient deficiency within a year of treatment initiation

We know how hard it is to durably achieve such changes, along with the undesirability (and uncertainty with respect to unknown side-effects) of having to take injectable drugs for many years, no less the cost of doing that